Andrew Oxtoby
Overview
Andrew Oxtoby received $3M in total compensation, including $397K in salary, at Aimmune Therapeutics in 2019.
Source: SEC filing on April 9, 2020.
Related executives
We found nine more executives who work or worked at Aimmune Therapeutics.
Jayson Dallas
Aimmune Therapeutics
Chief Executive Officer
Eric Bjerkholt
Aimmune Therapeutics
Chief Financial Officer
Douglas Sheehy
Aimmune Therapeutics
General Counsel
Daniel Adelman
Aimmune Therapeutics
Chief Medical Officer
Stephen Dilly
Aimmune Therapeutics
Chief Executive Officer
Susan Barrowcliffe
Aimmune Therapeutics
General Manager, Europe
Jeffrey Knapp
Aimmune Therapeutics
Chief Operating Officer
Warren DeSouza
Aimmune Therapeutics